Insider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells 11,011 Shares of Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now owns 64,308 shares of the company’s stock, valued at $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Teladoc Health Trading Up 3.1 %

Shares of Teladoc Health stock traded up $0.26 on Friday, hitting $8.43. The stock had a trading volume of 6,763,363 shares, compared to its average volume of 6,027,647. The stock has a 50 day moving average of $10.45 and a 200 day moving average of $9.72. The firm has a market capitalization of $1.46 billion, a P/E ratio of -1.46 and a beta of 1.27. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $15.68. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Sell-side analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have commented on TDOC. Oppenheimer reduced their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. The Goldman Sachs Group reduced their target price on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a report on Monday, March 3rd. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th. Royal Bank of Canada increased their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Finally, Piper Sandler reduced their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $11.26.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Arizona State Retirement System lifted its stake in shares of Teladoc Health by 1.8% in the fourth quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider’s stock worth $452,000 after acquiring an additional 859 shares during the period. Mercer Global Advisors Inc. ADV raised its holdings in Teladoc Health by 9.6% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider’s stock worth $113,000 after purchasing an additional 1,089 shares during the last quarter. Canada Pension Plan Investment Board boosted its stake in shares of Teladoc Health by 0.5% in the 4th quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider’s stock valued at $2,079,000 after purchasing an additional 1,200 shares during the last quarter. Summit Investment Advisors Inc. boosted its position in Teladoc Health by 8.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider’s stock valued at $164,000 after acquiring an additional 1,331 shares during the last quarter. Finally, Vise Technologies Inc. grew its stake in Teladoc Health by 4.9% during the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock worth $274,000 after purchasing an additional 1,405 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.